RemeGen Presents Oral Presentation on Evaluation of Its Proprietary Disitamab Vedotin (RC48) for Cervical Cancer at ESGO 2024
YANTAI, China, March 11, 2024 /PRNewswire/ -- RemeGen Co. Ltd.("RemeGen" or "the Company") (9995.HK,...
YANTAI, China, March 11, 2024 /PRNewswire/ -- RemeGen Co. Ltd.("RemeGen" or "the Company") (9995.HK,...
LAS VEGAS, March 11, 2024 /PRNewswire/ -- Baseus Technology, a prestigious global consumer electronics...
Enables the development and construction of BrightNight's 1 GWac Philippines renewables portfolio with an...
- The transaction represents a key milestone in ESR's stated strategy to streamline and...
Since 2021, the APPIS platform has brought together over 2,000 people from more than...
SINGAPORE, March 11, 2024 /PRNewswire/ -- Organised by Arts House Limited, Singapore International Festival...
At Europe's Largest HVAC Exhibition, Company Introduces Highly Energy-Efficient Residential and Commercial Solutions Designed to...
SUZHOU, China, March 11, 2024 /PRNewswire/ -- Gansu Golden Solar Co. Ltd., ("Golden Solar") a...
SINGAPORE, March 11, 2024 /PRNewswire/ -- NCH Asia Pacific, a global leader in industrial and...
© 2022 Siam News Network - Thailand Business News and advertising Network. Powered by VLoss.
© 2022 Siam News Network - Thailand Business News and advertising Network. Powered by VLoss.